Literature DB >> 7576340

HIV-1 group O sensitivity to antiretroviral drugs.

D Descamps, G Collin, I Loussert-Ajaka, S Saragosti, F Simon, F Brun-Vézinet.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7576340

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  10 in total

1.  Development and evaluation of a DNA enzyme immunoassay method for env genotyping of subtypes A through G of human immunodeficiency virus type 1 group M, with discrimination of the circulating recombinant forms CRF01_AE and CRF02_AG.

Authors:  Jean-Christophe Plantier; Laurence Vergne; Florence Damond; Souleymane MBoup; Eitel MPoudi-NGole; Laurence Buzelay; Isabelle Farfara; Denys Brand; Martine Peeters; Françoise Brun-Vézinet; Eric Delaporte; Francis Barin
Journal:  J Clin Microbiol       Date:  2002-03       Impact factor: 5.948

2.  Susceptibility of human immunodeficiency virus type 1 group O isolates to antiretroviral agents: in vitro phenotypic and genotypic analyses.

Authors:  D Descamps; G Collin; F Letourneur; C Apetrei; F Damond; I Loussert-Ajaka; F Simon; S Saragosti; F Brun-Vézinet
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

3.  Efficacy of dideoxynucleosides against human foamy virus and relationship to its reverse transcriptase amino acid sequence and structure.

Authors:  A Yvon-Groussin; P Mugnier; P Bertin; M Grandadam; H Agut; J M Huraux; V Calvez
Journal:  J Virol       Date:  2001-08       Impact factor: 5.103

4.  Human immunodeficiency virus type 1 subtype F reverse transcriptase sequence and drug susceptibility.

Authors:  C Apetrei; D Descamps; G Collin; I Loussert-Ajaka; F Damond; M Duca; F Simon; F Brun-Vézinet
Journal:  J Virol       Date:  1998-05       Impact factor: 5.103

5.  Discrimination of subtype B and non-subtype B strains of human immunodeficiency virus type 1 by serotyping: correlation with genotyping.

Authors:  G Murphy; F J Belda; C P Pau; J P Clewley; J V Parry
Journal:  J Clin Microbiol       Date:  1999-05       Impact factor: 5.948

6.  Characterization of a highly replicative intergroup M/O human immunodeficiency virus type 1 recombinant isolated from a Cameroonian patient.

Authors:  M Peeters; F Liegeois; N Torimiro; A Bourgeois; E Mpoudi; L Vergne; E Saman; E Delaporte; S Saragosti
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

7.  Analysis of pol gene heterogeneity, viral quasispecies, and drug resistance in individuals infected with group O strains of human immunodeficiency virus type 1.

Authors:  M E Quiñones-Mateu; J L Albright; A Mas; V Soriano; E J Arts
Journal:  J Virol       Date:  1998-11       Impact factor: 5.103

8.  Rapid assay for simultaneous detection and differentiation of immunoglobulin G antibodies to human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2.

Authors:  A S Vallari; R K Hickman; J R Hackett; C A Brennan; V A Varitek; S G Devare
Journal:  J Clin Microbiol       Date:  1998-12       Impact factor: 5.948

9.  Genetic divergence of human immunodeficiency virus type 1 Ethiopian clade C reverse transcriptase (RT) and rapid development of resistance against nonnucleoside inhibitors of RT.

Authors:  Hugues Loemba; Bluma Brenner; Michael A Parniak; Shlomo Ma'ayan; Bonnie Spira; Daniela Moisi; Maureen Oliveira; Mervi Detorio; Mark A Wainberg
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

Review 10.  Impact of human immunodeficiency virus (HIV) subtypes on HIV-associated neurological disease.

Authors:  Kevin J Liner; Colin D Hall; Kevin R Robertson
Journal:  J Neurovirol       Date:  2007-08       Impact factor: 2.643
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.